Literature DB >> 17479945

Disease burden of congenital toxoplasmosis.

A H Havelaar1, J M Kemmeren, L M Kortbeek.   

Abstract

Although the outcomes of toxoplasmosis have been well documented, an integrated estimate of the impact of this infection on the health status of the population is not available. "Disability-adjusted life years" are the sum of years of life lost and years lived with disability, weighted for the severity of the illness. The estimated disease burden of congenital toxoplasmosis in The Netherlands is 620 (range, 220-1900) disability-adjusted life years per year, which is similar to that for salmonellosis and is mainly caused by fetal loss and chorioretinitis. However, there is considerable uncertainty in this estimate. Scenario analysis indicates that the true burden may be underestimated. In other countries, the disease burden is expected to vary with the incidence of congenital infection, but it may also depend on the health care system. In countries that actively screen for toxoplasmosis, such as France, there may be a lower burden of morbidity but a higher burden of mortality.

Entities:  

Mesh:

Year:  2007        PMID: 17479945     DOI: 10.1086/517511

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  39 in total

Review 1.  A review on inactivation methods of Toxoplasma gondii in foods.

Authors:  Adel Mirza Alizadeh; Sahar Jazaeri; Bahar Shemshadi; Fataneh Hashempour-Baltork; Zahra Sarlak; Zahra Pilevar; Hedayat Hosseini
Journal:  Pathog Glob Health       Date:  2018-10-22       Impact factor: 2.894

2.  Estimates of the burden of foodborne illness in Canada for 30 specified pathogens and unspecified agents, circa 2006.

Authors:  M Kate Thomas; Regan Murray; Logan Flockhart; Katarina Pintar; Frank Pollari; Aamir Fazil; Andrea Nesbitt; Barbara Marshall
Journal:  Foodborne Pathog Dis       Date:  2013-05-09       Impact factor: 3.171

3.  Increased Toxoplasma gondii positivity relative to age in 125 Scottish sheep flocks; evidence of frequent acquired infection.

Authors:  Frank Katzer; Franz Brülisauer; Esther Collantes-Fernández; Paul M Bartley; Alison Burrells; George Gunn; Stephen W Maley; Chris Cousens; Elisabeth A Innes
Journal:  Vet Res       Date:  2011-12-21       Impact factor: 3.683

4.  Antenatal screening for mother to child infections in immigrants and residents: the case of toxoplasmosis in northern Italy.

Authors:  Lina Rachele Tomasoni; Elena Sosta; Anna Beltrame; Giada Rorato; Sara Bigoni; Tiziana Frusca; Cristina Zanardini; Lorenza Driul; Francesca Magrini; Pierluigi Viale; Francesco Castelli
Journal:  J Immigr Minor Health       Date:  2010-12

Review 5.  The impact of the waterborne transmission of Toxoplasma gondii and analysis efforts for water detection: an overview and update.

Authors:  Panagiotis Karanis; Hebatalla M Aldeyarbi; Marzieh E Mirhashemi; Khalil M Khalil
Journal:  Environ Sci Pollut Res Int       Date:  2012-09-19       Impact factor: 4.223

Review 6.  The global burden of congenital toxoplasmosis: a systematic review.

Authors:  Paul R Torgerson; Pierpaolo Mastroiacovo
Journal:  Bull World Health Organ       Date:  2013-05-03       Impact factor: 9.408

Review 7.  Epidemiology of and diagnostic strategies for toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Laure Dardé
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

8.  Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii.

Authors:  Leonardo Augusto; Jennifer Martynowicz; Kirk A Staschke; Ronald C Wek; William J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

Review 9.  Immune response and immunopathology during toxoplasmosis.

Authors:  Christopher D Dupont; David A Christian; Christopher A Hunter
Journal:  Semin Immunopathol       Date:  2012-09-07       Impact factor: 9.623

10.  Empowering women and improving female reproductive health through control of neglected tropical diseases.

Authors:  Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2009-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.